Report copyright - 2020 Medicines in Development ꟷ Cancer - PhRMA...(anti-PD1 mAb) North Chicago, IL solid tumors ABBV-184 AbbVie acute myeloid leukemia (AML), Phase I (surviving TCR/CD3 T cell engager)
Please pass captcha verification before submit form